These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
883 related articles for article (PubMed ID: 26851390)
21. Free Adriamycin-Loaded pH/Reduction Dual-Responsive Hyaluronic Acid-Adriamycin Prodrug Micelles for Efficient Cancer Therapy. Yin T; Wang Y; Chu X; Fu Y; Wang L; Zhou J; Tang X; Liu J; Huo M ACS Appl Mater Interfaces; 2018 Oct; 10(42):35693-35704. PubMed ID: 30259743 [TBL] [Abstract][Full Text] [Related]
22. Free paclitaxel-loaded E-selectin binding peptide modified micelle self-assembled from hyaluronic acid-paclitaxel conjugate inhibit breast cancer metastasis in a murine model. Han X; Dong X; Li J; Wang M; Luo L; Li Z; Lu X; He R; Xu R; Gong M Int J Pharm; 2017 Aug; 528(1-2):33-46. PubMed ID: 28576551 [TBL] [Abstract][Full Text] [Related]
23. Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice. Zou Y; Song Y; Yang W; Meng F; Liu H; Zhong Z J Control Release; 2014 Nov; 193():154-61. PubMed ID: 24852094 [TBL] [Abstract][Full Text] [Related]
24. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. Li J; Huo M; Wang J; Zhou J; Mohammad JM; Zhang Y; Zhu Q; Waddad AY; Zhang Q Biomaterials; 2012 Mar; 33(7):2310-20. PubMed ID: 22166223 [TBL] [Abstract][Full Text] [Related]
25. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy. Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241 [TBL] [Abstract][Full Text] [Related]
26. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer. Wang F; Li L; Liu B; Chen Z; Li C Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535 [TBL] [Abstract][Full Text] [Related]
27. The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel. Zhao BX; Zhao Y; Huang Y; Luo LM; Song P; Wang X; Chen S; Yu KF; Zhang X; Zhang Q Biomaterials; 2012 Mar; 33(8):2508-20. PubMed ID: 22197569 [TBL] [Abstract][Full Text] [Related]
28. Low-density lipoprotein-coupled micelles with reduction and pH dual sensitivity for intelligent co-delivery of paclitaxel and siRNA to breast tumor. Zhu WJ; Yang SD; Qu CX; Zhu QL; Chen WL; Li F; Yuan ZQ; Liu Y; You BG; Zhang XN Int J Nanomedicine; 2017; 12():3375-3393. PubMed ID: 28490877 [TBL] [Abstract][Full Text] [Related]
29. Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancer. Kim JE; Park YJ Int J Nanomedicine; 2017; 12():645-658. PubMed ID: 28176896 [TBL] [Abstract][Full Text] [Related]
30. N-acetylcysteine modified hyaluronic acid-paclitaxel conjugate for efficient oral chemotherapy through mucosal bioadhesion ability. Jin X; Asghar S; Zhang M; Chen Z; Huang L; Ping Q; Xiao Y Colloids Surf B Biointerfaces; 2018 Dec; 172():655-664. PubMed ID: 30243219 [TBL] [Abstract][Full Text] [Related]
31. A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel. Sun J; Chen Y; Li K; Huang Y; Fu X; Zhang X; Zhao W; Wei Y; Xu L; Zhang P; Venkataramanan R; Li S Acta Biomater; 2016 Oct; 43():282-291. PubMed ID: 27422196 [TBL] [Abstract][Full Text] [Related]
32. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting. Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430 [TBL] [Abstract][Full Text] [Related]
33. Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer. Lan Y; Sun Y; Yang T; Ma X; Cao M; Liu L; Yu S; Cao A; Liu Y Mol Pharm; 2019 Aug; 16(8):3430-3440. PubMed ID: 31199661 [TBL] [Abstract][Full Text] [Related]
34. Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance. Wang L; Jia E Drug Deliv; 2016 Jun; 23(5):1810-7. PubMed ID: 26530693 [TBL] [Abstract][Full Text] [Related]
35. Vitamin E-based redox-sensitive salinomycin prodrug-nanosystem with paclitaxel loaded for cancer targeted and combined chemotherapy. Liang DS; Liu J; Peng TX; Peng H; Guo F; Zhong HJ Colloids Surf B Biointerfaces; 2018 Dec; 172():506-516. PubMed ID: 30212688 [TBL] [Abstract][Full Text] [Related]
36. Exogenous vitamin C boosts the antitumor efficacy of paclitaxel containing reduction-sensitive shell-sheddable micelles in vivo. Zhu Y; Wang X; Zhang J; Meng F; Deng C; Cheng R; Feijen J; Zhong Z J Control Release; 2017 Mar; 250():9-19. PubMed ID: 28163212 [TBL] [Abstract][Full Text] [Related]
38. Co-Delivery of Paclitaxel and Doxorubicin by pH-Responsive Prodrug Micelles for Cancer Therapy. Jiang Y; Zhou Y; Zhang CY; Fang T Int J Nanomedicine; 2020; 15():3319-3331. PubMed ID: 32494132 [TBL] [Abstract][Full Text] [Related]
39. Self-assembled nanoparticles from hyaluronic acid-paclitaxel prodrugs for direct cytosolic delivery and enhanced antitumor activity. Xu C; He W; Lv Y; Qin C; Shen L; Yin L Int J Pharm; 2015 Sep; 493(1-2):172-81. PubMed ID: 26232702 [TBL] [Abstract][Full Text] [Related]
40. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles. Wu J; Zhang J; Deng C; Meng F; Zhong Z Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]